Company Profile
Updated: 18-SEP-09Amarillo Biosciences Inc.
Public Company, Headquarters Location
4134 Business Park Dr., Amarillo, TX 79110-4225, United States
(806)376-1741, (806)376-9301 fax, http://www.amarbio.com
Primary SIC: Commercial Physical & Bio Research, Primary NAICS: Research and Development in the Physical Sciences and Engineering Sciences
Description: Services: Research and development of biologics for the treatment of human and animal diseases.
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
AMARILLO BIOSCIENCES REPORTS ACQUISITION BY FORMER VP COY (Texas)
US Fed News Service, Including US State News; 11/7/2009; 316 words; WASHINGTON, Nov. 7 -- Amarillo Biosciences Inc. (AMAR.OB), Amarillo, Texas, has filed a Form 4 with the Securities and Exchange Commission noting the change in the beneficial interest held by Former VP and Chief Financial Officer Gary...
Other News To Note.
BIOWORLD Today; 11/4/2009; 2194 words; ...biological warfare agents. Amarillo Biosciences Inc., of Amarillo, Texas, signed a licensing...Damon will distribute in Korea Amarillo's dietary supplements for dry mouth. Amgen Inc., of Thousand Oaks, Calif...
Clinic Roundup.
BIOWORLD Today; 11/3/2009; 1833 words; o Amarillo Biosciences Inc., of Amarillo, Texas, said it submitted to the FDA a protocol for a Phase...Commercialization conference in Philadelphia. o DOV Pharmaceutical Inc., of Hackensack, N.J., said an in-depth analysis of its...
Appointments And Advancements.
BIOWORLD Today; 11/3/2009; 909 words; ...Peter Tombros chairman. Altus Pharmaceuticals Inc., of Cambridge, Mass., appointed Harry Penner to its board and audit committee. Amarillo Biosciences Inc., of Amarillo, Texas, appointed Gary Coy chief financial officer...
AMARILLO BIOSCIENCES REPORTS MULTIPLE TRANSACTIONS BY VP COY (Texas)
US Fed News Service, Including US State News; 10/31/2009; 316 words; WASHINGTON, Oct. 31 -- Amarillo Biosciences Inc. (AMAR.OB), Amarillo, Texas, has filed a Form 4 with the Securities and Exchange Commission noting the change in the beneficial interest held by Former VP and Chief Financial Officer Gary...
Recent News Articles
- Information on Amarillo Biosciences, Inc.. Available on Equedia.
M2 Presswire - August 17, 2009 - Amarillo Biosciences Inc - Therapeutic Competitors.
M2 Presswire - June 22, 2009 - Amarillo Biosciences, Inc. (ABI) (OTCBB: AMAR) Xtreme picks of the day!
M2 Presswire - June 19, 2009 - Amarillo Biosciences Inc. is in the StockGuru Spotlight for June 1, 2009.
M2 Presswire - June 01, 2009
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning